KIT: Kidney Injury Test is a revolution in kidney transplant monitoring.


LEARN MORE

What is KIT?

FACTS ABOUT TRANSPLANTATION

There is a large unmet clinical need in the field of kidney post-transplant monitoring.

Percent of transplants undergoing acute rejection15%
Number of transplants that have failed by 10 years42%
Percent of transplant wait list waiting for a kidney83%
Survival of patients after 1st year of transplant95%
Percent of transplant physicians who want more sensitive diagnostics100%

FEATURES OF THE KIT ASSAY

We have developed a noninvasive, sensitive, and inexpensive assay to monitor kidney damage.

PROTECTIVE

Earlier detection of kidney injury and subsequent intervention can extend the lifespan of the transplant

INEXPENSIVE

Our assay is affordable and much cheaper than a renal biopsy.

TIMESAVER

Our product is reliable and easy-to-use, giving a quick turn-around time.

PERSONALIZED

By looking at a patient’s specific trend over time, a physician can notice significant changes in kidney injury and intervene.

MEET THE TEAM


Our team is composed of a mix of scientific research experience and business leadership in order to leverage our individual talents to make the KIT assay a success.

Joshua Yang, MTM - He conducts research on the role of cell-free DNA as a biomarker in immune-mediated diseases, for which he has won national awards such as the Barry H. Goldwater scholarship. He has published in the transplantation field.

Joshua Yang, MTM

Co-Founder

Drew Watson, PhD, MBA – He is a biostatistician and computational biologist with over 25 years' experience in the fields of large-scale genomics, genetics, and clinical studies applied to the development of molecular based diagnostics and pharmaceuticals. Recognized expert in the fields of quality management and process improvement applied to electronics, manufacturing, instrumentation and software development.

Drew Watson, PhD, MBA

Co-Founder

MEET THE ADVISORS

Our mentors and advisers have a backgrounds in science, startups, and business.

Assistant Professor in the UCSF School of Medicine in the Department of Surgery

Tara Sigdel, PhD

Chief Scientific Officer (CSO) of Progenity and former CEO of Carmenta Bioscience

Matthew Cooper, MBA, PhD

Associate at McKinsey & Company

Arunan Skandarajan

KEEP UPDATED WITH KIT

We’ll keep you updated on the latest KIT news!

OUR AWARDS

Programs and awards that we have received for KIT.